Pancreatic Ductal Adenocarcinoma (PDAC)
By far the most common type, accounting for around 90% of all pancreatic cancers. PDAC starts in the cells that line the pancreatic ducts and is the most aggressive form. Treatment depends heavily on stage — surgery is curative for early-stage disease, while advanced disease is treated with combination chemotherapy and emerging targeted and immunotherapy options.